Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Buyout of AmeriPath Riles Some Shareholders

Dispute over proposed sale to Welsh Carson provides an inside peek into the deal structure

CEO SUMMARY: Owners of the few remaining independent private laboratory companies closely watch prices paid by lab buyers. In the pending sale of AmeriPath to private equity investor Welsh, Carson, Anderson, & Stowe, dissenting shareholders disclosed several aspects of the valuation process. This information provides useful insights into the process of valuing laboratory companies. DISSENTING …

Buyout of AmeriPath Riles Some Shareholders Read More »

To access this post, you must purchase The Dark Report.



You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.